LeadStory

CBS America

FDA begins review of mifepristone, abortion access at stake

CBS America · Just In
CBS America
CBS America
Just In

Health Secretary Robert F. Kennedy Jr. has launched an FDA review of mifepristone, the drug used in two-thirds of all abortions. Advocates warn that restrictions could limit access even in states where abortion remains legal, sparking debate over reproductive rights.

Breakdown
  • The FDA has begun a review of mifepristone, a drug used in most U.S. abortions.
  • Medical experts and organizations maintain that mifepristone is safe and effective. 29s
  • The review was prompted by a report from a conservative think tank alleging higher complication rates. 1m 17s
  • Other data sources show serious complications from mifepristone are much rarer than claimed in the report. 1m 36s
  • Potential policy changes could restrict access to mifepristone, though a full ban would likely face legal challenges. 1m 46s
Social IssuesPoliticsHealth